Lack of Evidence for Ribavirin Monotherapy Efficacy on Liver Fibrosis in Hepatitis C Virus Positive Renal Transplant Patients
- 1 June 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 79 (12) , 1770-1771
- https://doi.org/10.1097/01.tp.0000158279.29506.e0
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Histopathologic Efficacy of Ribavirin Monotherapy in Kidney Allograft Recipients with Chronic Hepatitis CTransplantation, 2004
- Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histologyAmerican Journal of Kidney Diseases, 2003
- Evaluation of hepatitis B and hepatitis C virus-infected renal allograft recipients with liver biopsy and noninvasive parametersAmerican Journal of Kidney Diseases, 2003
- Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infectionGastroenterology, 2002
- Severe evolution of chronic hepatitis C in renal transplantation: a case control studyNephrology Dialysis Transplantation, 2002